Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04531787 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 139
- Enrollment target
NCT04531787: Completed study, sponsored by University of Wisconsin, Madison.
NCT04531787 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04531787 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibodies in lung transplant patients between seasons.
Primary Outcome
A protective influenza antibody concentration is a titer of greater than or equal to 1:40. Influenza antibody concentrations were measured using hemagglutination inhibition assays.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-07 |
What the finished NCT04531787 record still lists
NCT04531787 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04531787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04531787 about?
NCT04531787 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibo...
What is the current status of trial NCT04531787?
This trial is currently completed. The enrollment target is 139 participants. The study started on 2004-08. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04531787?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04531787?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia